H.B.4406. Health; controlled substances; prescription drug and opioid abuse commission; require to provide recommendations for the instruction of pupils on prescription opioid drug abuse. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7113a.

Michigan House of Representatives
Last action 8 months ago
Polls (closed):
Yay (0)    Nay (0)

Summary

                    House Bill 4406 would add a section to the Public Health Code (proposed MCL 333.7113a), which would require the Prescription Drug and Opioid Abuse Commission to develop and provide recommendations for the instruction of students on prescription opioid drug abuse to the Michigan Department of Education (MDE) by January 1, 2018.  These must include recommendations for instruction on the prescription drug epidemic and the connection between prescription drug epidemic and the connection between prescription opioid drug abuse and addiction to other drugs.
                
Advertisment
why ads?


                    [The Commission, created within the Michigan Department of Licensing and Regulatory Affairs (LARA) by Governor Snyder's Executive Order No. 2016-15,[1] replaced the Controlled Substances Advisory Commission and the Advisory Committee on Pain and Symptom Management.  It was charged with reviewing the 2015 Report of Findings and Recommendations for Action from the Michigan Prescription Drug and Opioid Abuse Task Force, and developing and proposing policies to implement those recommendations, among other tasks.].

This analysis was prepared by nonpartisan House Fiscal Agency staff for use by House members in their deliberations, and does not constitute an official statement of legislative intent.
                

In an effort to be an unbiased source of information, all text in this summary comes directly from government resources.

Actions

  • assigned PA 254'17 with immediate effect

    Wed, Dec 27th 2017
  • presented to the Governor 12/18/2017 @ 11:18 AM

    Wed, Dec 27th 2017
  • filed with Secretary of State 12/27/2017 @ 2:32 PM

    Wed, Dec 27th 2017
  • approved by the Governor 12/27/2017 @ 12:19 PM

    Wed, Dec 27th 2017
  • SUBSTITUTE S-1 CONCURRED IN

    Tue, Dec 12th 2017
  • bill ordered enrolled

    Tue, Dec 12th 2017
  • full title agreed to

    Tue, Dec 12th 2017
  • Roll Call # 506 Yeas 105 Nays 5

    Tue, Dec 12th 2017
  • Senate substitute S-1 concurred in

    Tue, Dec 12th 2017
  • rule suspended

    Tue, Dec 12th 2017
  • laid over one day under the rules

    Tue, Dec 12th 2017
  • returned from Senate with substitute S-1 with immediate effect and full title

    Tue, Dec 12th 2017
  • REPORTED FAVORABLY WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • COMMITTEE RECOMMENDED IMMEDIATE EFFECT

    Tue, Dec 12th 2017
  • REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • INSERTED FULL TITLE

    Tue, Dec 12th 2017
  • PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE S-1

    Tue, Dec 12th 2017
  • RULES SUSPENDED

    Tue, Dec 12th 2017
  • PLACED ON IMMEDIATE PASSAGE

    Tue, Dec 12th 2017
  • PASSED; GIVEN IMMEDIATE EFFECT ROLL CALL # 532 YEAS 37 NAYS 1 EXCUSED 0 NOT VOTING 0

    Tue, Dec 12th 2017
  • REFERRED TO COMMITTEE ON HEALTH POLICY

    Tue, Jun 13th 2017
  • read a third time

    Mon, Jun 12th 2017
  • transmitted

    Mon, Jun 12th 2017
  • passed; given immediate effect Roll Call # 203 Yeas 102 Nays 5

    Mon, Jun 12th 2017
  • read a second time

    Tue, Jun 6th 2017
  • placed on third reading

    Tue, Jun 6th 2017
  • referred to second reading

    Tue, May 23rd 2017
  • reported with recommendation without amendment

    Tue, May 23rd 2017
  • bill electronically reproduced 03/23/2017

    Mon, Mar 27th 2017
  • read a first time

    Wed, Mar 22nd 2017
  • referred to Committee on Health Policy

    Wed, Mar 22nd 2017
  • introduced by Representative Beth Griffin

    Wed, Mar 22nd 2017